| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Issuance( Retirement)of Debt Net | 0.60 | 0.46 | -0.19 | 3.46 |
| Net Changein Cash | -0.02 | 0.07 | 0.02 | 2.47 |
| Cash Taxes Paid | 0.20 | 0.22 | 0.38 | 0.67 |
| Net Income/ Starting Line | 0.69 | 0.63 | 1.25 | 2.25 |
| Changesin Working Capital | -0.41 | -3.25 | -2.84 | -4.64 |
| Cashfrom Operating Activities | 3.72 | 0.79 | 1.66 | 0.77 |
| Cash Interest Paid | 2.03 | 1.87 | 1.64 | 1.41 |
| Cashfrom Financing Activities | -1.43 | 0.28 | 0.62 | 1.68 |
| Issuance( Retirement)of Stock Net | 0.00 | 0.68 | 1.89 | - |
| Depreciation/ Depletion | 1.43 | 1.56 | 1.63 | 1.76 |
| Other Investing Cash Flow Items Total | 0.01 | 0.01 | -1.41 | 0.01 |
| Capital Expenditures | -2.33 | -1.02 | -0.86 | 0.00 |
| period Type | - | - | - | - |
| Non- Cash Items | 2.01 | 1.86 | 1.63 | 1.40 |
| Financing Cash Flow Items | -2.03 | -0.86 | -1.07 | -1.78 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Cashfrom Investing Activities | -2.32 | -1.01 | -2.27 | 0.01 |
Concord Drugs Dividend Concord Drugs Bonus Concord Drugs News Concord Drugs AGM Concord Drugs Rights Concord Drugs Splits Concord Drugs Board Meetings Concord Drugs Key Metrics Concord Drugs Shareholdings Concord Drugs Profit Loss Concord Drugs Balance Sheet Concord Drugs Q1 Results Concord Drugs Q2 Results Concord Drugs Q3 Results Concord Drugs Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks